Literature DB >> 17981050

Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility.

Francesco Errico1, Robert Nisticò, Giuseppe Palma, Mauro Federici, Andrea Affuso, Elisa Brilli, Enza Topo, Diego Centonze, Giorgio Bernardi, Yuri Bozzi, Antimo D'Aniello, Roberto Di Lauro, Nicola B Mercuri, Alessandro Usiello.   

Abstract

In the present study, we demonstrate a direct role for d-aspartate in regulating hippocampal synaptic plasticity. These evidences were obtained using two different experimental strategies which enabled a non-physiological increase of endogenous d-aspartate levels in the mouse hippocampus: a genetic approach based on the targeted deletion of d-aspartate oxidase gene and another based on the oral administration of d-aspartate. Overall, our results indicate that increased d-aspartate content does not affect basal properties of synaptic transmission but enhances long-term potentiation in hippocampal slices from both genetic and pharmacological animal models. Besides electrophysiological data, behavioral analysis suggests that altered levels of d-aspartate in the hippocampus do not perturb basal spatial learning and memory abilities, but may selectively interfere with the dynamic NMDAR-dependent processes underlying cognitive flexibility.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17981050     DOI: 10.1016/j.mcn.2007.09.012

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  26 in total

Review 1.  Non-coding RNA regulation of synaptic plasticity and memory: implications for aging.

Authors:  Laurie R Earls; Joby J Westmoreland; Stanislav S Zakharenko
Journal:  Ageing Res Rev       Date:  2014-03-27       Impact factor: 10.895

2.  Physiological evidence that D-aspartate activates a current distinct from ionotropic glutamate receptor currents in Aplysia californica neurons.

Authors:  Stephen L Carlson; Lynne A Fieber
Journal:  J Neurophysiol       Date:  2011-07-13       Impact factor: 2.714

Review 3.  D-Aspartate acts as a signaling molecule in nervous and neuroendocrine systems.

Authors:  Nobutoshi Ota; Ting Shi; Jonathan V Sweedler
Journal:  Amino Acids       Date:  2012-08-08       Impact factor: 3.520

4.  In Vitro Metabolomic Approach to Hippocampal Neurodegeneration Induced by Trimethyltin.

Authors:  Zdenka Gasparova; Nada Pronayova; Veronika Stara; Tibor Liptaj
Journal:  Neurochem Res       Date:  2015-10-19       Impact factor: 3.996

5.  Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia.

Authors:  Byron K Y Bitanihirwe; Daria Peleg-Raibstein; Forouhar Mouttet; Joram Feldon; Urs Meyer
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

6.  Chiral resolution of plasma amino acids reveals enantiomer-selective associations with organ functions.

Authors:  Masataka Suzuki; Ryoko Shimizu-Hirota; Masashi Mita; Kenji Hamase; Jumpei Sasabe
Journal:  Amino Acids       Date:  2022-02-28       Impact factor: 3.520

7.  A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice.

Authors:  F Errico; V D'Argenio; F Sforazzini; F Iasevoli; M Squillace; G Guerri; F Napolitano; T Angrisano; A Di Maio; S Keller; D Vitucci; A Galbusera; L Chiariotti; A Bertolino; A de Bartolomeis; F Salvatore; A Gozzi; A Usiello
Journal:  Transl Psychiatry       Date:  2015-02-17       Impact factor: 6.222

8.  Human D-aspartate Oxidase: A Key Player in D-aspartate Metabolism.

Authors:  Loredano Pollegioni; Gianluca Molla; Silvia Sacchi; Giulia Murtas
Journal:  Front Mol Biosci       Date:  2021-06-23

9.  Mice overexpressing type 1 adenylyl cyclase show enhanced spatial memory flexibility in the absence of intact synaptic long-term depression.

Authors:  Ming Zhang; Hongbing Wang
Journal:  Learn Mem       Date:  2013-06-14       Impact factor: 2.460

10.  Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis.

Authors:  Silvia Rossi; Valeria Studer; Alessandro Moscatelli; Caterina Motta; Giancarlo Coghe; Giuseppe Fenu; Stacy Caillier; Fabio Buttari; Francesco Mori; Francesca Barbieri; Maura Castelli; Valentina De Chiara; Fabrizia Monteleone; Raffaele Mancino; Giorgio Bernardi; Sergio E Baranzini; Maria G Marrosu; Jorge R Oksenberg; Diego Centonze
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.